Trends in Waiting List Registration for Liver Transplantation for Viral Hepatitis in the United States
To access this article, please choose from the options below
Conflicts of interest The authors disclose the following: W. Ray Kim received a grant from the Gilead Sciences, Inc, to conduct this study. He has served as a consultant for Roche, Bristol–Myers–Squibb, Idenix, Schering-Plough, and Gilead Sciences. Norah Terrault has received grants from Gilead Sciences, Cangene, NABI, and Roche and consulted Bristol-Myers-Squibb. Andrew Hindman was a former employee of Gilead Sciences, Inc, and Carol Brosgart was a former employee of Gilead Sciences. Terry Therneau, Rachel Pedersen, and Erick Edwards disclose no conflicts.
Funding Supported by grants from the National Institute of Diabetes, Digestive and Kidney Diseases (DK-34238 and DK-61617), and Gilead Sciences, Inc, provided unrestricted grant in partial support of the work; however, the content of the work including data analysis and interpretation was solely that of the authors.
PII: S0016-5085(09)01246-3
doi:10.1053/j.gastro.2009.07.047
© 2009 AGA Institute. Published by Elsevier Inc. All rights reserved.

